1. Home
  2. ICD-10-CM Codes
  3. C00–D49
  4. D3A
  5. D3A
  6. 2024 ICD-10-CM Code D3A
Version 2024
Non-Billable Code

2024 ICD-10-CM Diagnosis Code D3A

Benign neuroendocrine tumors

ICD-10-CM Code:
D3A
ICD-10 Code for:
Benign neuroendocrine tumors
Is Billable?
Not Valid for Submission
Code Navigator:

Code Classification

  • Neoplasms
    (C00–D49)
    • Benign neuroendocrine tumors
      (D3A)
      • Benign neuroendocrine tumors
        (D3A)

D3A is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of benign neuroendocrine tumors. The code is not specific and is NOT valid for the year 2024 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

Specific Coding Applicable to Benign neuroendocrine tumors

Non-specific codes like D3A require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10-CM codes with a higher level of specificity when coding for benign neuroendocrine tumors:

  • D3A.0 for Benign carcinoid tumors - NON-BILLABLE CODE

  • Use D3A.00 for Benign carcinoid tumor of unspecified site - BILLABLE CODE

  • D3A.01 for Benign carcinoid tumors of the small intestine - NON-BILLABLE CODE

  • D3A.02 for Benign carcinoid tumors of the appendix, large intestine, and rectum - NON-BILLABLE CODE

  • D3A.09 for Benign carcinoid tumors of other sites - NON-BILLABLE CODE

  • Use D3A.8 for Other benign neuroendocrine tumors - BILLABLE CODE

Tabular List of Diseases and Injuries

The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.


Code Also

Code Also
A "code also" note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction.
  • any associated multiple endocrine neoplasia MEN syndromes E31.2

Use Additional Code

Use Additional Code
The “use additional code” indicates that a secondary code could be used to further specify the patient’s condition. This note is not mandatory and is only used if enough information is available to assign an additional code.
  • code to identify any associated endocrine syndrome, such as:
  • carcinoid syndrome E34.0

Type 2 Excludes

Type 2 Excludes
A type 2 excludes note represents "Not included here". An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.
  • benign pancreatic islet cell tumors D13.7

Patient Education


Benign Tumors

Tumors are abnormal growths in your body. They can be either benign or malignant. Benign tumors aren't cancer. Malignant ones are. Benign tumors grow only in one place. They cannot spread or invade other parts of your body. Even so, they can be dangerous if they press on vital organs, such as your brain.

Tumors are made up of extra cells. Normally, cells grow and divide to form new cells as your body needs them. When cells grow old, they die, and new cells take their place. Sometimes, this process goes wrong. New cells form when your body does not need them, and old cells do not die when they should. These extra cells can divide without stopping and may form tumor.

Treatment often involves surgery. Benign tumors usually don't grow back.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.